The U.S. Food and Drug Administration (FDA) has approved a medicine (teclistamab) produced by Johnson & Johnson for therapy of multiple myeloma, or the type of blood cancer. Prior to this, the medicine has already been conditionally approved by the European drug regulator in August.
The European Commission said Tuesday that U.S. tobacco company Philip Morris has obtained permission from the European Union's antitrust agency to buy Swedish Match for $16 billion. The acquisition comes despite the giant's earlier statements on selling its logistics business.
Google has stated that it has a long history of protecting the privacy of its users, including pushing back against overbroad government demands for user data.
Philip Morris is planning to receive approval from European Union competition authorities to acquire Swedish Match for $16 billion on condition that the logistics unit of the company will be sold.
India's antitrust watchdog has ordered Google to reconsider their approach to Android platforms. Using unfair competition practices led to the company’s fine of 13.38 billion Indian rupees ($161.95 million).
Elon Musk, the CEO of Tesla, said that the new version of the advanced driver assistance system or “Full Self-Driving” (FSD) still hasn't received approval from the relevant authorities, because the authorities don’t believe in the possibility of driving a car without the direct presence of a person.
Boeing Co. wants to convince the U.S. Congress to extend the deadline for certifying two new variants of the 737 MAX.
Bitcoin and Ethereum dropped sharply Wednesday, October 19, during morning trading on the Asian market. The reason is the European Union (EU) to consider a bill that says the mining process of energy-intensive cryptocurrencies, including Bitcoin, may be restricted.
It was revealed that the papers submitted by the planemaker Boeing for certification of its 737 MAX 7 airliner, don’t contain all the necessary documents, and some of the documents require review by the manufacturer. Boeing was informed about this by the US Federal Aviation Administration.
On October 17, it was revealed that Moderna, an American biotech company, will provide the world's poorest countries with a new adapted version of the COVID-19 vaccine.
